Hypothyroidism Hasan AYDIN MD Yeditepe University Medical Faculty

  • Slides: 57
Download presentation
Hypothyroidism Hasan AYDIN, MD Yeditepe University Medical Faculty Endocrinology and Metabolism Page

Hypothyroidism Hasan AYDIN, MD Yeditepe University Medical Faculty Endocrinology and Metabolism Page

Definition A deficiency of thyroid hormones, which in turn results in a generalized slowing

Definition A deficiency of thyroid hormones, which in turn results in a generalized slowing down of metabolic processes. Page 2

Page

Page

Hypothyroidism Epidemiology – Most common endocrine disease – Females > Males – 8 :

Hypothyroidism Epidemiology – Most common endocrine disease – Females > Males – 8 : 1 Presentation – Often unsuspected and grossly under diagnosed – 90 % of the cases are Primary Hypothyroidism – Menstrual irregularities, miscarriages, growth retard. – Vague pains, anaemia, lethargy, gain in weight – In clear cut cases - typical signs and symptoms Page 4

Disease Burden 5% of the general population are “Subclinically Hypothyroid” 15 % of all

Disease Burden 5% of the general population are “Subclinically Hypothyroid” 15 % of all women > 65 yrs. are hypothyroid Detecting sub-clinical hypothyroidism in pregnancy is highly essential Page 5 All persons aged above 60 years – Order for TSH

Etiology Page

Etiology Page

Causes of Hypothyroidism Primary – Congenital – Acquired – Transient Secondary – Pituitary –

Causes of Hypothyroidism Primary – Congenital – Acquired – Transient Secondary – Pituitary – Hypothalamic Page 7

Congenital Hypothyroidism Athyreosis Dyshormonogenesis – Sodium/iodide symporter mutations – TPO mutations – Thyroglobulin gene

Congenital Hypothyroidism Athyreosis Dyshormonogenesis – Sodium/iodide symporter mutations – TPO mutations – Thyroglobulin gene mutations – Deiodinase defects Thyroid hormone resistance TSH-receptor defect Page 8

Acquired Hypothyroidism Iodine deficiency Autoimmune thyroid disease – Hashimoto’s , Graves disease Iatrogenic –

Acquired Hypothyroidism Iodine deficiency Autoimmune thyroid disease – Hashimoto’s , Graves disease Iatrogenic – Post-thyroidectomy – Radioactive iodine treatment – Thyroid irradiation – Medications/goitrogens Page 9

Hashimoto’s Disease Struma lymphomatosa : firm, enlarged thyroid Antibodies to thyroid antigens (TPO, Thyroglobulin,

Hashimoto’s Disease Struma lymphomatosa : firm, enlarged thyroid Antibodies to thyroid antigens (TPO, Thyroglobulin, TSH receptor, T 4 , T 3 ) Cellular abnormalities (increased CD 8+ T cells, aberrant HLA-DR expression, increased NK/K cells and cytokines) Slowly progressive disease (10 % hypothyroid) Associated with other autoimmune disease Page 10

Transient Hypothyroidism Subacute thyroiditis (de Quervain’s) Silent thyroiditis Post-partum thyroiditis (Hashimoto’s) Transient neonatal hypothyroidism

Transient Hypothyroidism Subacute thyroiditis (de Quervain’s) Silent thyroiditis Post-partum thyroiditis (Hashimoto’s) Transient neonatal hypothyroidism Page 11

Secondary Hypothyroidism Pituitary – Tumor – Infectious disease – Infiltrating disease – Vascular insufficiency

Secondary Hypothyroidism Pituitary – Tumor – Infectious disease – Infiltrating disease – Vascular insufficiency – TRH deficiency – Empty sella syndrome – Iatrogenic Page 12 Hypothalamic

Manifestations Page

Manifestations Page

Manifestations Page 14

Manifestations Page 14

Skin and Appendages – Myxedema (hyaluronic acid accumulation) – Pale, cool and dry skin,

Skin and Appendages – Myxedema (hyaluronic acid accumulation) – Pale, cool and dry skin, hypercarotenemia – Tongue is enlarged – Thickened laryngeal/pharyngeal mucous membranes – Slow wound healing, bruising – Dry, brittle hair – Temporal loss of eyebrows – Brittle nails Page 15

Page 16

Page 16

Cardiovascular System – Decreased cardiac output (stroke volume + heart rate) – Increased peripheral

Cardiovascular System – Decreased cardiac output (stroke volume + heart rate) – Increased peripheral vascular resistance – Narrow pulse pressure – Pericardial effusion, dilated myocardium – Coronary atherosclerosis (HT, HL) – ECG changes (bradycardia, low amplitude QRS, prolonged PR, ST alterations) Page 17

Respiratory System – Pleural effusions – Decreased ventilatory drive (hypercapnia, hypoxemia) – Involvement of

Respiratory System – Pleural effusions – Decreased ventilatory drive (hypercapnia, hypoxemia) – Involvement of respiratory muscles – Obstructive sleep apnea Page 18

Gastrointestinal – Delayed peristalsis, distension, constipation – Ascitis (rare) – Achlorhydria and pernicious anemia

Gastrointestinal – Delayed peristalsis, distension, constipation – Ascitis (rare) – Achlorhydria and pernicious anemia – Reduced appetite Page 19

Musculoskletal – Delayed, abnormal epiphyseal ossification – Impaired linear growth (short limbs) and bone

Musculoskletal – Delayed, abnormal epiphyseal ossification – Impaired linear growth (short limbs) and bone age – Myalgias (inflamation, infiltration) – Joint effusions Page 20

Neuropsychiatric – Decreased cerebral perfusion, myelination, and cortical development- retardation – Slow speech, lack

Neuropsychiatric – Decreased cerebral perfusion, myelination, and cortical development- retardation – Slow speech, lack of concentration and memory, depression, paranoia – Delay in the relaxation phase of DTR – Delayed nerve conduction, carpal tunnel syndrome – Perceptive hearing loss (Pendred Synd. ) Page 21

Reproductive System – Delayed puberty – Oligomenorrhea and menorrhagia – Reduced fertility – Oligospermia

Reproductive System – Delayed puberty – Oligomenorrhea and menorrhagia – Reduced fertility – Oligospermia and erectile dysfunction – Hyperprolactinemia Page 22

Other – Decreased erythropoetin (anemia) – Decreased Factor 8 and 9 – Low basal

Other – Decreased erythropoetin (anemia) – Decreased Factor 8 and 9 – Low basal metabolic rate – Increased cholesterol, TG, LDL and decreased HDL Page 23

Infantile Hypothyroidism (Cretinism) Retardation of mental development and growth Protuberant abdomen, umblical hernia, dry

Infantile Hypothyroidism (Cretinism) Retardation of mental development and growth Protuberant abdomen, umblical hernia, dry skin, poor hair and nail growth, delayed teeth eruption, waddling gait Epiphysial dysgenesis Page 24

Congenital Hypothyroidism Page 25

Congenital Hypothyroidism Page 25

Myxedema Coma Severe myxedema, bradycardia, hypotension, subnormal temperature, seizures Alveolar hypoventilation, dilutional hyponatremia are

Myxedema Coma Severe myxedema, bradycardia, hypotension, subnormal temperature, seizures Alveolar hypoventilation, dilutional hyponatremia are common Exposure to cold, infection, trauma, central nervous system depressants trigger coma Page 26

Myxedema Page 27

Myxedema Page 27

Myxedema Page 28

Myxedema Page 28

Solid Oedema Page 29 Xanthomata

Solid Oedema Page 29 Xanthomata

Diagnosis Page

Diagnosis Page

Laboratory Tests TSH T 3 and T 4 Thyroid antibodies RAIU Serum lipids CK,

Laboratory Tests TSH T 3 and T 4 Thyroid antibodies RAIU Serum lipids CK, SGOT, LDH Hemogram Page 31

Differential Diagnosis Elderly patients Chronic renal failure Nephrotic states Pernicious anemia Euthyroid Sick Syndrome

Differential Diagnosis Elderly patients Chronic renal failure Nephrotic states Pernicious anemia Euthyroid Sick Syndrome Down Syndrome Page 32

Co-morbidity Hypercholesterolemia Depression Infertility – Menstrual Irregularities Diabetes mellitus Page 33

Co-morbidity Hypercholesterolemia Depression Infertility – Menstrual Irregularities Diabetes mellitus Page 33

Hypothyroidism and Hypercholesterolemia 14% of patients with elevated cholesterol have hypothyroidism Approximately 90% of

Hypothyroidism and Hypercholesterolemia 14% of patients with elevated cholesterol have hypothyroidism Approximately 90% of patients with overt hypothyroidism have increased cholesterol and / or triglycerides Page 34

Lipids in Patient with Hypothyroidism Hypercholesterolemi a (>200 mg/d. L) Hypertriglyceridemia (>150 mg/d. L)

Lipids in Patient with Hypothyroidism Hypercholesterolemi a (>200 mg/d. L) Hypertriglyceridemia (>150 mg/d. L) N= 268 Hypercholesterolemi a and mild Hyper TG Normal Lipids Page 35

LDL-C Levels Increase With Increasing Hypothyroidism Grade 246 191 LDL-C (mg/d. L 168 Hypothyroidism

LDL-C Levels Increase With Increasing Hypothyroidism Grade 246 191 LDL-C (mg/d. L 168 Hypothyroidism Grade 144 133 137 C 1 2 Basal TSH (m. U/L) 1. 1 63. 7 Page 36 3. 0 3 8. 6 4* 22. 7 5† 44. 4

Hypothyroidism and Depression Depressive symptoms are common in hypothyroidism Many hypothyroid patients fulfill DSM-IV

Hypothyroidism and Depression Depressive symptoms are common in hypothyroidism Many hypothyroid patients fulfill DSM-IV criteria for a depressive disorder Depressed patients may be more likely than normal individuals to be hypothyroid All depressed patients should be evaluated for thyroid dysfunction Page 37

Hypothyroidism and Depression Sleep decrease Suicidal ideation Weight change Delusions Page 38 Hypothyroidism Constipation

Hypothyroidism and Depression Sleep decrease Suicidal ideation Weight change Delusions Page 38 Hypothyroidism Constipation Bradycardia Decreased Conc. Cardiac and lipid Decreased libido Depressed mood Abnormalities Diminished interest. Cold intolerance Weight increase Hair and skin changes Fatigue Delayed reflexes Goiter

Hypothyroidism and Infertility 1. Hypothyroidism associated with infertility, miscarriage, stillbirth 2. Infertility : Evaluate

Hypothyroidism and Infertility 1. Hypothyroidism associated with infertility, miscarriage, stillbirth 2. Infertility : Evaluate thyroid function, treat hypothyroidism 3. Equivocal results: Begin therapy; discontinue if no pregnancy for several months. Page 39

Suspect Hypothyroidism 1. Amenorrhea 2. Oligomenorrhea 3. Menorrhogia 4. Galactorrhea 5. Premature ovarian failure

Suspect Hypothyroidism 1. Amenorrhea 2. Oligomenorrhea 3. Menorrhogia 4. Galactorrhea 5. Premature ovarian failure 6. Infertility 7. Decreased libido 8. Precocious / delayed puberty Page 40

Hypothyroidism and Diabetes 1. Approximately 10% of patients with type 1 diabetes mellitus develop

Hypothyroidism and Diabetes 1. Approximately 10% of patients with type 1 diabetes mellitus develop sub-clinical hypothyroidism 2. In diabetic patients - examine for goitre 3. TSH measurement at regular intervals Page 41

Hormone Replacement Page

Hormone Replacement Page

Many Causes, One Treatment Goal : Normalize TSH level regardless of cause of hypothyroidism

Many Causes, One Treatment Goal : Normalize TSH level regardless of cause of hypothyroidism Treatment : Once daily dosing with Levothyroxine sodium (1. 6 µg/kg/day) Monitor TSH levels at 6 to 8 weeks, after initiation of therapy or dosage change Page 43

Many Causes, One Treatment of choice is levothyroxin Branded thyroxine recommended Brand consistency recommended

Many Causes, One Treatment of choice is levothyroxin Branded thyroxine recommended Brand consistency recommended No divided doses - illogical Not recommended for use : Page 44 l Desiccated thyroid extract l Combination of thyroid hormones l T 3 replacement except in Myxedema coma

Dosage Adjustments Age (in elderly start with half dose) Severity and duration of hypothyroidism

Dosage Adjustments Age (in elderly start with half dose) Severity and duration of hypothyroidism (↑ dose) Weight (0. 5µg/kg/day ↑ upto 3. 0µg/kg/day) Malabsorption (requires ↑ dose) Concomitant drug therapy (only on empty stomach) Pregnancy ( 25% ↑ in dose), safe in lactating mother Presence of cardiac disease (start alt. day Rx) Page 45

Start Low and Go Slow Starting dose for healthy patients < 50 years at

Start Low and Go Slow Starting dose for healthy patients < 50 years at 1. 0 µg/kg/day Starting dose for healthy patients > 50 years should be < 0, 50 µg/day. Dose ↑ by 25 µg, if needed, at 6 to 8 weeks intervals. Starting dose for patients with heart disease should be Page 46 12. 5 to 25 µg/day and increase by 12. 5 to 25 µg/day, if

How the Patient Improves l Feels better in 2 – 3 weeks l Reduction

How the Patient Improves l Feels better in 2 – 3 weeks l Reduction in weight is the first improvement l Facial puffiness then starts coming down l Skin changes, hair changes take long time to regress l TSH starts showing decrements from the high values l TSH returns to normal eventually Page 47

Drug Interactions Reduced Absorption Page 48 l Cholestyramine resin l Sucralfate l Drugs that

Drug Interactions Reduced Absorption Page 48 l Cholestyramine resin l Sucralfate l Drugs that affect metabolism l Rifampin Ferrous sulfate l Carbamazepine l Soybean formula l Phenytoin l Aluminum hydroxide l Colestipol hydrochloride l Phenobarbitol l Amiodarone

Inappropriate Dosage Over-replacement risks Reduced bone density / osteoporosis Tachycardia, arrhythmia. atrial fibrillation In

Inappropriate Dosage Over-replacement risks Reduced bone density / osteoporosis Tachycardia, arrhythmia. atrial fibrillation In elderly or patients with heart disease, angina, arrhythmia, or myocardial infarction Under-replacement risks Continued hypothyroid state Long-term end-organ effects of hypothyroidism Increased risk of hyperlipidemia Page 49

Special Situations Page

Special Situations Page

Sub-clinical Hypothyroidism Chronic autoimmune thyroiditis Graves’ hyperthyroidism with radioiodine, surgery Inadequate replacement therapy for

Sub-clinical Hypothyroidism Chronic autoimmune thyroiditis Graves’ hyperthyroidism with radioiodine, surgery Inadequate replacement therapy for hypothyroidism Lithium carbonate therapy (for depressive illness) Page 51

Subclinical Hypothyroidism High TSH with normal Free T 4 Commonest cause is chronic autoimmune

Subclinical Hypothyroidism High TSH with normal Free T 4 Commonest cause is chronic autoimmune thyroiditis (Hashimoto’s disease) Associated with increased titer of antithyroid antibodies: - Anti thyroglobulin autobodies - Antimicrosomal (Antiperoxidase) antibodies Suspected with thyroid enlargement but may be associated with atrophy Page 52

Prognosis May stay sub clinical May progress to clinical 5% per year with positive

Prognosis May stay sub clinical May progress to clinical 5% per year with positive antibodies In elderly risk is 20%/ year Page 53

Post-Partum Thyroiditis Definition Occurrence of hyperthyroidism and / or hypothyroidism during the postpartum period

Post-Partum Thyroiditis Definition Occurrence of hyperthyroidism and / or hypothyroidism during the postpartum period in women who were euthryroid during pregnancy At Highest Risk Patients with type 1 diabetes, previous history of PPT or other autoimmune disease such as Hashimoto’s disease and Graves’ disease Page 54

Sick Euthyroid Syndrome l Total T 3 reduced l FT 3 reduced l Total

Sick Euthyroid Syndrome l Total T 3 reduced l FT 3 reduced l Total T 4 reduced l FT 4 Normal l TSH Normal l Clinically Euthyroid Page 55

Normal T 4, High TSH, Two readings, six weeks apart TSH between 5 -10

Normal T 4, High TSH, Two readings, six weeks apart TSH between 5 -10 m. U/L TSH >10 m. U/L Check Thyroid antibodies Antibodies or symptoms present Positive Therapy Negative Symptoms positive Therapy Page 56 Antibodies negative or no symptoms Consider therapy No symptoms Observe, test every six months

Thank You Page

Thank You Page